A. N. Shoutko, L. Yurkova, K. S. Borodulya, L. P. Ekimova
{"title":"New-Competitive- Principal of Tumor Control by Low Dose Radiation","authors":"A. N. Shoutko, L. Yurkova, K. S. Borodulya, L. P. Ekimova","doi":"10.9734/bpi/nfmmr/v12/12422d","DOIUrl":null,"url":null,"abstract":"In order to verify the principle of indirect control a tumor on the base of morphogenic cells distraction from it, the 114 patients with advanced ovarian carcinoma (stage III-56, stage IY-21, relapse 37), were treated with subtotal half-body (low part) irradiation at low doses (0,1 Gy x 10 for 3 weeks or 3Gy x 3 daily), and obtained data were compared with that for 190 patients (stage III-66, stage IY-25, relapse-99) received conventional local irradiation of the tumor (2 Gy x 23 daily). The surgery and chemotherapy components were equalized in both groups. The 34% and 11% of 5-years survival was obtained at low dose half body irradiation for primary and relapsed patients in comparison with conventional local radiotherapy (7% and 0%). It is concluded, that reparation /regeneration processes being provoked artificially in normal tissues of cancer host are capable to compete remotely with tumor for the morphogenic/feeding cells originated from bone marrow and circulating with the blood.","PeriodicalId":118581,"journal":{"name":"New Frontiers in Medicine and Medical Research Vol. 12","volume":"216 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"New Frontiers in Medicine and Medical Research Vol. 12","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9734/bpi/nfmmr/v12/12422d","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
In order to verify the principle of indirect control a tumor on the base of morphogenic cells distraction from it, the 114 patients with advanced ovarian carcinoma (stage III-56, stage IY-21, relapse 37), were treated with subtotal half-body (low part) irradiation at low doses (0,1 Gy x 10 for 3 weeks or 3Gy x 3 daily), and obtained data were compared with that for 190 patients (stage III-66, stage IY-25, relapse-99) received conventional local irradiation of the tumor (2 Gy x 23 daily). The surgery and chemotherapy components were equalized in both groups. The 34% and 11% of 5-years survival was obtained at low dose half body irradiation for primary and relapsed patients in comparison with conventional local radiotherapy (7% and 0%). It is concluded, that reparation /regeneration processes being provoked artificially in normal tissues of cancer host are capable to compete remotely with tumor for the morphogenic/feeding cells originated from bone marrow and circulating with the blood.
为了验证间接控制肿瘤的原则的基础上地貌成因的细胞分散,114年晚期卵巢癌患者癌(IY-21 III-56阶段,阶段,复发37),服用小计一半身体(低部分)在低剂量辐照(0,1 Gy x 10 3周或3 Gy x 3日报),和获得的数据相比,190名患者(阶段3 - 66、舞台IY-25、复发- 99)接受传统的局部照射肿瘤(2 Gy x 23日报)。两组的手术和化疗成分相等。与常规局部放疗(7%和0%)相比,低剂量半体照射对原发和复发患者的5年生存率分别为34%和11%。由此可见,在肿瘤宿主的正常组织中,人工激活的修复/再生过程能够与肿瘤进行远程竞争,争夺来自骨髓并随血液循环的形态形成/喂养细胞。